Abcam RabMAbs - rabbit monoclonal antibodies

Thursday, 22 November, 2012 | Supplied by: Sapphire Bioscience

Rabbit monoclonal antibodies (RabMAbs) provide the combined benefits of good antigen recognition of the rabbit immune system with the specificity and consistency of a monoclonal antibody.

Produced through a proprietary method, the antibodies have the following advantages: diverse epitope recognition; improved immune response to small-size epitopes; high specificity and affinity; improved response to mouse antigens.

There are currently more than 3600 RabMAbs in the product range. Each antibody is tested for use in western blot, immunohistochemistry, immunocytochemistry and ELISA.

Online: www.sapphirebioscience.com
Phone: 02 9698 2022

Content from other channels on our network

SA Government puts Whyalla Steelworks under administration

HRS Heat Exchangers announces partnership with Fluid Dynamics

Deakin research partnership to test fuel cells for aviation

Three kinds of artificial intelligence: from predictive to prescriptive and beyond

CSIRO offers free R&D training for Queensland SMEs

Survey puts health workforce retention strategies in focus

Victoria improves nurse and midwife to patient ratios

AI cardiac tool trialled in SA hospitals gets assessed by ... AI

How and why safety and quality standards are evolving

RACGP sets out "accessible, affordable" GP care plan

City dwellers at higher risk of heatwave death

Three-point plan to fight battery-related fires

US federal paper straw ban causes confusion, expert says

ANC Delivers boosts battery-electric vehicle fleet

Schneider Electric appoints Tim Pratt as VP Power Products

Abcam RabMAbs - rabbit monoclonal antibodies

Cayman Chemical Natural Products Screening Library

AdipoGen Life Sciences DYRK inhibitors

GroPep Bioreagents IGF-1 Family Proteins

Content from other channels on our network